Literature DB >> 1648979

Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell line.

A Cohen1, T Grunberger, W Vanek, I D Dube, P J Doherty, M Letarte, C Roifman, M H Freedman.   

Abstract

A cell line (B1) was established from the bone marrow of a patient with a relapse of acute leukemia characterized by a 4;11 chromosomal translocation and biphenotypic features of early B and myeloid lineages. Analysis of the growth requirements of this cell line showed density-dependent growth and secretion of an autostimulatory growth factor, suggesting an autocrine mechanism. Several lines of evidence implicate the participation of interleukin-1 (IL-1) in the autocrine growth regulation of B1 cells. These cells constitutively express the messenger RNA (mRNA) for IL-1 and IL-1 receptor and secrete IL-1; recombinant IL-1 stimulated the growth of colonies when cells were seeded at low density, and anti-IL-1 antibodies inhibited the growth of colonies with cells seeded at higher density. B1 cells do not express detectable levels of mRNA for any of the other cytokines tested, and other cytokines failed to support the growth of B1 cells at low density. In addition, B1 cells express multiple cytokine receptor genes, including the receptors for IL-6, IL-7, tumor necrosis factor and gamma-interferon. Addition of the respective cytokines to the B1 cells resulted in inhibition of the growth of leukemic cells in vitro. The multiplicity of growth-inhibitory cytokine receptors on this leukemic cell line might be due to its biphenotypic lineage and may suggest new therapeutic possibilities in controlling leukemic cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648979

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.

Authors:  P H Domer; S S Fakharzadeh; C S Chen; J Jockel; L Johansen; G A Silverman; J H Kersey; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

2.  Detection of chromosome 11q23 involving translocations by pulsed field gel electrophoresis.

Authors:  J Finke; R Kunzmann; W Lange
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

3.  Expression of cytokines and their receptors by human thymocytes and thymic stromal cells.

Authors:  S S Wolf; A Cohen
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

4.  Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.

Authors:  T Morisaki; D L Morton; A Uchiyama; D Yuzuki; A Barth; D S Hoon
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

5.  The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase.

Authors:  Y Gu; G Cimino; H Alder; T Nakamura; R Prasad; O Canaani; D T Moir; C Jones; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  Expansion of CD3+CD4-CD8- T cell population expressing high levels of IL-5 in Omenn's syndrome.

Authors:  I Melamed; A Cohen; C M Roifman
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

7.  Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.

Authors:  Kimberley A Hoeksema; Aarthi Jayanthan; Todd Cooper; Lia Gore; Tanya Trippett; Jessica Boklan; Robert J Arceci; Aru Narendran
Journal:  Onco Targets Ther       Date:  2011-09-05       Impact factor: 4.147

8.  The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.

Authors:  Denise Ragusa; Evgeny M Makarov; Oliver Britten; Daniela Moralli; Catherine M Green; Sabrina Tosi
Journal:  Cancer Rep (Hoboken)       Date:  2019-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.